Authors: DEGAST GC HAAGEN IA VANHOUTEN AA KLEIN SC DUITS AJ DEWEGER RA VROOM TM CLARK MR PHILLIPS J VANDIJK AJG DELAU WBM BAST BJEG

Citation: Gc. Degast et al., CD8 T-CELL ACTIVATION AFTER INTRAVENOUS ADMINISTRATION OF CD3XCD19 BISPECIFIC ANTIBODY IN PATIENTS WITH NON-HODGKIN-LYMPHOMA, Cancer immunology and immunotherapy, 40(6), 1995, pp. 390-396

Authors: VANHOUTEN AA HAAGEN IA CLARK M GEERARS A DELAU W BAST EJEG DEGAST GC

Citation: Aa. Vanhouten et al., FIRST RESULTS OF INTRAVENOUS APPLICATION OF BISPECIFIC ANTIBODY (CD3 CD19 SHR-1) TO PATIENTS WITH CD19 POSITIVE B-CELL MALIGNANCIES - A PHASE-1 STUDY/, Experimental hematology, 21(8), 1993, pp. 1120-1120

Authors: VANHOUTEN AA HAAGEN IA CLARK M GEERARS A DELAU W VROOM TM BAST EJEG DEGAST GC

Citation: Aa. Vanhouten et al., CYTOKINE RELEASE AFTER INTRAVENOUS ADMINISTRATION OF BISPECIFIC ANTIBODY (CD3 CD19, SHR-1) - A PHASE-I STUDY IN PATIENTS WITH CD19 POSITIVEB-CELL MALIGNANCIES/, Blood, 82(10), 1993, pp. 10000580-10000580